Jason Mehar

Investments & Deputy General Counsel

Jason joined Royalty Pharma in 2018. Previously, Jason was an associate in the Mergers & Acquisitions groups of Gibson, Dunn & Crutcher and Davis Polk & Wardwell. Jason has a BA in business from York University and a JD from Osgoode Hall Law School.

Necessary

These cookies are required for the website to work and to remember your cookie choices. They cannot be switched off in this tool.

Name	Provider	Purpose	Expiration
moove_gdpr_popup	Royalty Pharma	Remembers your cookie preference and consent category choices for this website.	1 year
__cf_bm	Cloudflare	Supports bot management and security protection for the website and hosted resources.	30 minutes
_cfuvid	Cloudflare	Helps apply rate limiting and distinguish visitors who share an IP address.	Session
_GRECAPTCHA	Google reCAPTCHA	Helps protect forms from spam and abuse by supporting reCAPTCHA risk analysis.	179 days

Analytics

These cookies help us understand how people use the website so we can improve content and performance. They are only used if you allow analytics cookies.

Name	Provider	Purpose	Expiration
_ga	Google Analytics	Distinguishes visitors for website analytics and measurement.	399 days
_ga_N7PN9PKQBL	Google Analytics	Stores and counts page views for the GA4 property used by this website.	399 days
_hjSession_3631739	Hotjar	Maintains data for the current Hotjar analytics session.	30 minutes
_hjSessionUser_3631739	Hotjar	Persists a site-specific Hotjar user ID so later visits can be attributed to the same analytics user.	365 days
vuid	Vimeo	Stores a Vimeo-generated ID used to generate analytics information for the video owner.	399 days
__uxq412__id.9a22	Q4 / Q4Web	Used by Q4 investor-relations tooling to measure engagement with investor content, including visitor identification for page-view activity.	364 days
__uxq412__ses.9a22	Q4 / Q4Web	Used by Q4 investor-relations tooling to measure engagement with investor content during a browsing session.	30 minutes

Jason Mehar

Stay up to date